Keratitis

Keratitis
Classification and external resources

An eye with non-ulcerative sterile keratitis.
ICD-10 H16
ICD-9 370
DiseasesDB 7150
MeSH D007634

Keratitis is a condition in which the eye's cornea, the front part of the eye, becomes inflamed. The condition is often marked by moderate to intense pain and usually involves impaired eyesight.[1]

Contents

Types

Superficial keratitis involves the superficial layers of the cornea. After healing, this form of keratitis does not generally leave a scar.

Deep keratitis involves deeper layers of the cornea, and the natural course leaves a scar upon healing that impairs vision if on or near the visual axis. This can be reduced or avoided with the use of topical corticosteroid eyedrops.

Causes

Keratitis has multiple causes, one of which is an infection of a present or previous herpes simplex virus secondary to an upper respiratory infection, involving cold sores.

Pathogens

Other

Diagnosis

Effective diagnosis is important in detecting this condition and subsequent treatment as keratitis is sometimes mistaken for an allergic conjunctivitis.

Treatment

Treatment depends on the cause of the keratitis. Infectious keratitis can progress rapidly, and generally requires urgent antibacterial, antifungal, or antiviral therapy to eliminate the pathogen. Treatment is usually carried out by an ophthalmologist and can involve prescription eye medications, systemic medication, or even intravenous therapy. It is inadvisable to use over-the-counter eye drops as they are typically not helpful in treating infections, also using them could delay correct treatment, increasing the likelihood of sight threatening complications. In addition, contact lens wearers are typically advised to discontinue contact lens wear and replace contaminated contact lenses and contact lens cases. (Contaminated lenses and cases should not be discarded as cultures from these can be used to identify the pathogen).

Antibacterial solutions include Quixinex (levofloxacin), Zymar (gatifloxacin), Vigamox (moxifloxacin), Ocuflox (ofloxacin — available generically). Steroid containing medications should not be used for bacterial infections, as they may exacerbate the disease and lead to severe corneal ulceration and corneal perforation. These include Maxitrol (neomycin+polymyxin+dexamethasone — available generically), as well as other steroid medications.. One should consult an ophthalmologist or optometrist for treatment of an eye condition.

Some infections may scar the cornea to limit vision. Others may result in perforation of the cornea, (an infection inside the eye), or even loss of the eye. With proper medical attention, infections can usually be successfully treated without long-term visual loss.

See also

References

  1. ^ Keratitis
  2. ^ Martín-Navarro, M.; Lorenzo-Morales, J.; Cabrera-Serra, G.; Rancel, F.; Coronado-Alvarez, M.; Piñero, E.; Valladares, B. (Nov 2008). "The potential pathogenicity of chlorhexidine-sensitive Acanthamoeba strains isolated from contact lens cases from asymptomatic individuals in Tenerife, Canary Islands, Spain". Journal of medical microbiology 57 (Pt 11): 1399–1404. doi:10.1099/jmm.0.2008/003459-0. ISSN 0022-2615. PMID 18927419.  edit
  3. ^ CDC Advisory
  4. ^ Tang A, Marquart ME, Fratkin JD, McCormick CC, Caballero AR, Gatlin HP, O'Callaghan RJ (2009). "Properties of PASP: A Pseudomonas Protease Capable of Mediating Corneal Erosions". Invest Ophthalmol Vis Sci 50 (8): 3794–801. doi:10.1167/iovs.08-3107. PMC 2874894. PMID 19255155. http://www.pubmedcentral.nih.gov/articlerender.fcgi?tool=pmcentrez&artid=2874894. 
  5. ^ "What is onchocerciasis?". CDC. http://www.cdc.gov/ncidod/dpd/parasites/onchocerciasis/factsht_onchocerciasis.htm#what. Retrieved 2010-06-28. "transmission is most intense in remote African rural agricultural villages, located near rapidly flowing streams...(WHO) expert committee on onchocerciasis estimates the global prevalence is 17.7 million, of whom about 270,000 are blind." 
  6. ^ Optometry.co.uk
  7. ^ VET.uga.edu

External links